相似文献
1
Inhibition of classical C5 convertase in the complement system by factor H.
Immunology. 1983 Dec;50(4):631-5.
2
Regulation of C5 convertase activity by properdin, factors B and H.
Immunol Res. 1989;8(4):305-15. doi: 10.1007/BF02935515.
3
A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
J Clin Invest. 1985 Jun;75(6):1786-95. doi: 10.1172/JCI111891.
4
Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Eur J Immunol. 1984 Dec;14(12):1111-4. doi: 10.1002/eji.1830141209.
5
Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
J Exp Med. 1987 Jun 1;165(6):1494-507. doi: 10.1084/jem.165.6.1494.
6
Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement.
J Immunol. 1983 Jun;130(6):2821-4.
7
The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.
8
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600. doi: 10.1073/pnas.76.12.6596.
9
Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
Infect Immun. 1990 Aug;58(8):2535-41. doi: 10.1128/iai.58.8.2535-2541.1990.
10
Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
Clin Exp Immunol. 1982 Oct;50(1):209-14.
引用本文的文献
1
Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP).
Clin Exp Immunol. 1998 Sep;113(3):353-9. doi: 10.1046/j.1365-2249.1998.00663.x.
本文引用的文献
1
The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
J Immunol. 1980 Jan;124(1):326-31.
2
Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
J Exp Med. 1983 Apr 1;157(4):1239-51. doi: 10.1084/jem.157.4.1239.
3
The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
Biochem J. 1981 Dec 1;199(3):485-96. doi: 10.1042/bj1990485.
4
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
5
Cross-linking of aminotyrosyl residues in the active site of staphylococcal nuclease.
J Biol Chem. 1969 Jan 25;244(2):406-12.
6
An incompatibility in the reaction of the second component of human complement with the fourth component of guinea-pig complement.
Immunology. 1970 Feb;18(2):203-12.
7
A new complement inhibitor in guinea pig serum.
Jpn J Exp Med. 1969 Oct;39(5):527-31.
8
Enharncement of the hemolytic activity of the second component of human complement by oxidation.
J Exp Med. 1967 Dec 1;126(6):1013-25. doi: 10.1084/jem.126.6.1013.
9
Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.
J Immunol. 1967 Aug;99(2):263-8.
10
Control of the amplification convertase of complement by the plasma protein beta1H.
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72. doi: 10.1073/pnas.73.9.3268.
Zotero 插件